-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634.P1.90 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster I

Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Srdan Verstovsek, MD, PhD1, Andrew Kuykendall, MD2, Ronald Hoffman, MD3, Steffen Koschmieder4, Francesco Passamonti, MD5*, Frank Valone, MD6*, Nishit B. Modi, PhD6*, Sarita Khanna, PhD6*, Paula G. O'Connor, MD6*, Suneel K. Gupta, PhD6 and Jean-Jacques Kiladjian, MD7

1Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
4Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, University Hospital of Aachen, Aachen, Germany
5Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy
6Protagonist Therapeutics, Inc, Newark, CA
7Hôpital Saint-Louis; Université de Paris, INSERM, Paris, France Centre d’Investigations Cliniques, Université Paris, AP-HP, Hôpital Saint-Louis, Paris, France

Daniel J. DeAngelo, MD, PhD1*, Deepti H. Radia, MRCPI, FRCPath2*, Tracy I. George, MD3, William A. Robinson, MD, PhD4*, Albert T. Quiery, MD5,6, Mark W. Drummond, PhD, FRCPath7*, Prithviraj Bose, MD8, Elizabeth O. Hexner, MD, MSTR9, Elliott Winton, MD10, Hans-Peter Horny, MD11*, Meera Tugnait, PhD12*, Hui-Min Lin, PhD13*, Saša Dimitrijević, PhD14*, Javier I. Munoz-Gonzalez, PhD14*, Ilda Bidollari, MD, MBA13*, Michael W. Deininger, MD, PhD15 and Jason Gotlib, MD, MS16

1Dana-Farber Cancer Institute, Boston, MA
2Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
3ARUP Laboratories, Salt Lake City, UT
4UC Denver, Aurora, CO
5University of Michigan, Ann Arbor, MI
6U of M Cancer Center, Ann Arbor, MI
7Beatson Cancer Centre, Glasgow, United Kingdom
8The University of Texas MD Anderson Cancer Center, Houston, TX
9Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, Philadelphia, PA
10Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
11Institute of Pathology, Ludwig-Maximilians University, Munich, Germany
12Cerevel Therapeutics, Cambridge, MA
13Blueprint Medicines Corporation, Cambridge, MA
14Blueprint Medicines (Switzerland) GmbH, Zug, Switzerland
15Versiti Blood Research Institute, Milwaukee, WI
16Department of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, San Carlos, CA

Vikas Gupta, MD, FRCP, FRCPath1, Abdulraheem Yacoub, MD2, Srdan Verstovsek, MD, PhD3, Ruben Mesa, MD, FACP4, Claire N. Harrison, DM5, Alessandro M. Vannucchi, MD6*, Jean-Jacques Kiladjian7*, H. Joachim Deeg, MD8, Salman Fazal, MD9*, Lynda Foltz10*, Ryan J. Mattison, MD11, Carole B. Miller, MD12*, Vinod Parameswaran, MD13*, Patricia Martin-Regueira, MD14*, Christopher Hernandez, MSc14*, Jia Wang14* and Moshe Talpaz, MD15*

1Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
2The University of Kansas Hospital, Kansas City, KS
3MD Anderson Cancer Center, Houston, TX
4Mays Cancer Center, San Antonio, TX
5Guy's Hospital, London, ENG, United Kingdom
6Università di Firenze, AOU Careggi, CRIMM, Florence, Italy
7Hopital Saint-Louis et Universite Paris, Paris, France
8Fred Hutchinson Cancer Research Center, Seattle, WA
9Allegheny Health Network, Pittsburgh, PA
10University of British Columbia, Vancouver, BC, Canada
11University of Wisconsin Hospitals, Madison, WI
12Ascension Saint Agnes Cancer Institute, Baltimore, MD
13Avera Cancer Institute, Sioux Falls, SD
14Bristol Myers Squibb, Princeton, NJ
15University of Michigan, Ann Arbor, MI

Jeanne M. Palmer, MD1, Aaron T. Gerds, MD, MS2, Claire N. Harrison, DM3,4, Jean-Jacques Kiladjian, MD5, Sarah Buckley, MD6*, Karisse Roman-Torres6*, John Mascarenhas, MD7 and Ruben Mesa, MD, FACP8

1Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
2Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
3Guys and St Thomas NHS Trust, London, United Kingdom
4Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
5Hopital Saint-Louis, Paris, France
6CTI BioPharma, Seattle, WA
7Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
8Mays Cancer Center at UT Health San Antonio, San Antonio, TX

Terrence Bradley, MD1, Andrew Kuykendall, MD2, Rami S. Komrokji3, Tymara Berry, MD4*, Souria Dougherty, BS, MBA4*, Laurie Sherman, BSN4, Lixian Peng, PhD4*, Fei Huang, PhD4, Ying Wan, PhD4*, Faye Feller, MD4 and John Mascarenhas, MD5

1University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
4Geron Corporation, Parsippany, NJ
5Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Sanjay R Mohan, MD, MSCI1, Stephen T Oh, MD, PhD2, Haris Ali, MD3, Anthony M. Hunter, MD4*, Francesca Palandri, PhD, MD5*, Betty Lamothe, PhD6, Yi Cui, PhD6*, Francis Seguy, MSc7*, Amanda McBride, MD, PhD6, Michael Robert Savona8*, Jean-Jacques Kiladjian, MD9 and Srdan Verstovsek, MD, PhD10

1Vanderbilt University School of Medicine, Vanderbilt Ingram Cancer Center, Nashville, TN
2Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
3City of Hope Medical Center, Duarte, CA
4Emory University School of Medicine, Atlanta, GA
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
6Incyte Corporation, Wilmington, DE
7Incyte Biosciences International Sàrl, Morges, Switzerland
8Vanderbilt University Medical Center, Nashville, TN
9Hopital Saint-Louis, Paris, France
10Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX

Naseema Gangat, MBBS1, Kebede H. Begna, MD2, Aref Al-Kali, MD1, William J. Hogan, MB, BCh1, Mark R. Litzow, MD1, Animesh Pardanani, MBBS, PhD 1 and Ayalew Tefferi, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Divison of Hematology, Mayo Clinic, Rochester, MN

Ross Baker, MBBS, BMedSc1*, Jana Baskar, MBBS, MMedSc2*, Brett Charlton, MD, PhD2*, Gabriela S. Hobbs, MD3, Wolfgang Jarolimek, PhD2*, Sung-Eun Lee, MD4*, Lucia Masarova, MD5 and Anne-Marie Watson, MBBS, FRACP, FRCPA6

1Perth Blood Institute, Murdoch University, Perth, Australia
2Pharmaxis Ltd, Frenchs Forest, NSW, Australia
3Cancer Center, Massachusetts General Hospital, Boston, MA
4Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Liverpool Hospital, Sydney, NSW, Australia

Marie H. Kristiansen, MD1,2*, Vibe Skov, PhD3*, Lasse Kjær, PhD3*, Morten Kranker Kranker Larsen, MSc1,3*, Christina Ellervik, PhD1,4,5*, Hans Carl Hasselbalch, MD1,3 and Troels Wienecke, PhD1,2*

1Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2Department of Neurology, Zealand University Hospital, Roskilde, Denmark
3Department of Hematology, Zealand University Hospital, Roskilde, Denmark
4Department of Data and Data Support, Region Zealand, Sorø, Denmark
5Department of Pathology, Harvard Medical School, Boston, MA

Tim Kong, MS1, LaYow Yu2*, Angelo BA Laranjeira, PhD2*, Fan He, PhD2, Maggie J. Allen, BS2* and Stephen T Oh, MD, PhD1

1Division of Hematology, Washington University School of Medicine, St. Louis, MO
2Division of Hematology, Washington University School of Medicine in St. Louis, Saint Louis, MO

Erin Peckham-Gregory, PhD, MPH1, Priya B Shetty, PhD2*, Howard Lin, BS3*, Brooks Scull, MS3*, Erik Ehli, PhD4*, Kenneth L. McClain, MD, PhD5, Philip J. Lupo, Ph.D., M.P.H.6*, Carl E. Allen, MD, PhD7 and Michael E. Scheurer, PhD, MPH8*

1Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
2Baylor College of Medicine, Houston
3Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX
4Avera Institute for Human Genetics, Sioux Falls
5Texas Childrens Cancer and Hematology Centers, Houston, TX
6Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX
7Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX
8Texas Children's Hematology Center, Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX

Chiara Maccari1*, Benedetta Sordi, MD.1*, Paola Guglielmelli, MD, PhD2, Manjola Balliu, PhD1*, Alessandro Atanasio, MD1*, Carmela Mannarelli, PhD1*, Giulio Capecchi, MD1*, Ilaria Sestini, LabTech3*, Giacomo Coltro, MD1*, Giada Rotunno, PhD1*, Eva Angori, BiSc Stud4*, Filippo C. Borri, MedStud4*, Natasha Szuber, MD, MSc5 and Alessandro Vannucchi, MD1

1CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
2CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
3CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Florence, Italy
4University of Florence, Florence, Italy
5Maisonneuve-Rosemont Hospital, Department of Hematology, Montreal, QC, Canada

Shiwei Hu1,2,3*, Danhong Xiang1,2,3*, Min Yang, M.D.1* and Jian Huang, MD, PhD1,2,3

1Department of Hematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
2Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China
3Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China

Guangshuai Teng1*, Yuhui Zhang1*, Chenxiao Du1*, Yan Wang2*, Naibo Hu1*, Yingdi Han1*, Jinyu Ma2*, Shan Gao2*, Guangpeng Xiang2*, Zonghong Shao1 and Jie Bai, MD1

1Department of Hematology, The Second Hospital of Tianjin Medical University, Tianjin, China
2Second Hospital of Tianjin Medical University, tianjin, China

Ghaith Abu-Zeinah, MD1, Spencer Krichevsky, MS2,3*, Katie Erdos2*, Richard T. Silver, MD2 and Joseph Scandura, MD, PhD2

1Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Cornell, New York, NY
2Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY
3Department of Biomedical Informatics, State University of New York at Stony Brook, Stony Brook, NY

Abdulrahman F Al-Mashdali, MD1*, Alaa Rahhal2*, Mahmood B Aldapt, MBBS3, Elrazi Awadelkarim Ali1*, Yousef Mohammed Hailan, MBBS4*, Waail Rozi Kashgary1* and Mohamed A Yassin, MBBS, MSC, CABM, MSC, FACP5

1Internal Medicine, Hamad Medical Corporation, Doha, Qatar
2Pharmacy Department, Hamad Medical corporation, Doha, Qatar
3National Center for Cancer Care and Research HMC, Doha, Qatar
4Department of Medicine, Hamad Medical Corporation, Doha, Qatar
5Department of Medical Oncology/ Hematology Section, National Centre For Cancer Care & Research, Doha, Qatar

Xin Yan, MD1*, Zefeng Xu1*, Shiqiang Qu1*, Tiejun Qin1*, Gang Huang, PhD2, Zhijian Xiao, MD&PhD3* and Bing Li, MD1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Jean-Jacques Kiladjian, MD1, Françoise Boyer perrard2*, Kamel Laribi, MD3*, Jean-Christophe Ianotto, MD, PhD4*, Dana Ranta, MD5*, Omar Benbrahim, MD6*, Serge Bologna, MD7*, Pascale Cony-Makhoul, MD8*, Alberto Santagostino9*, Hacene Zerazhi10*, Abla Slimani11*, Olivier Fitoussi, MD12* and Gabriel Etienne, MD, PhD13*

1Centre d’Investigations Cliniques, Hôpital Saint-Louis, Paris, France
2Service des maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
3Hématologie clinique, CH Le Mans, Le Mans, France
4Clinical Hematology, Institut de Cancéro-Hématologie, Brest University Hospital, Brest, France
5Centre Hospitalier Universitaire, Nancy, France
6Hematology Department, CHR Orléans, Orleans, France
7Clinique Louis Pasteur, Essey-lès-Nancy, France
8Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France
9Hematology, CH de Troyes, Troyes, France
10Hématologie, CH Avignon, Avignon, France
11Novartis, Rueil Malmaison, WY, France
12Service d’oncologie-hématologie-radiothérapie, Polyclinique Bordeaux-Nord, Bordeaux, France
13Hematology Department, Institut Bergonié, Bordeaux, France

Johannes Lübke, MD1*, Nicole Naumann, PhD1*, Sebastian Kreil, MD, PhD1*, Georgia Metzgeroth, MD1*, Hans-Peter Horny, MD2*, Karl Sotlar, MD3*, Nicholas C.P. Cross, PhD4, Alice Fabarius, PhD1*, Peter Valent, MD5,6, Wolf-Karsten Hofmann, MD1, Juliana Schwaab, MD1* and Andreas Reiter, MD7

1Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
2Institute of Pathology, Ludwig-Maximilians-University, Munich, Munich, Germany
3Institute of Pathology, Medical University of Salzburg, Salzburg, Austria
4Faculty of Medicine, University of Southampton, Southampton, United Kingdom
5Ludwig Boltzmann Institute for Hematology and Oncology, Vienna, Austria
6Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
7Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany

Laura F. Mendez, MD, PhD1, Jiarui Li, RD2*, Julio Avelar-Barragan3*, Jenny Nguyen4*, Hellen Nguyen4*, Heidi E. Kosiorek, MS5*, Ruben Mesa, MD, FACP6, Robyn Marie Scherber, MD, MPH7*, Katrine Whiteson, PhD8*, Andrew Odegaard, PhD, MPH9* and Angela G Fleischman, MD, PhD3

1University of California Irvine, Irvine, CA
2Department of Epidemiology, University of California, Irvine, Irvine, CA
3University of California, Irvine, Irvine, CA
4Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA
5Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
6Mays Cancer Institute, UT Health San Antonio MD Anderson, San Antonio, TX
7Mays Cancer Center at UT Health San Antonio and MD Anderson Cancer Center, San Antonio, TX
8UNIVERSITY OF CALIFORNIA, IRVINE, IRVINE, CA
9Department of Epidemiology, University of California Irvine, Irvine, CA

Aaron T. Gerds, MD, MS1, Claire N. Harrison, DM2, Stephen Thompson3*, Frank Snopek, PharmD3* and Naveen Pemmaraju, MD4

1Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
2Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
3Sierra Oncology, Inc., San Mateo, CA
4MD Anderson Cancer Center, Houston, TX

Christopher J. Saunders, MD1*, Chandan Saha1*, Priya Sriskandarajah1*, Helen Cashman2*, Andrew J Wilson2*, Jonathan Lambert2*, Matthew Lawes3*, David Tucker, MD4*, Simone Green5*, Manish Jain6*, Victoria Stables7*, Juanah Addada8*, Theingi Yin9*, Huw Roddie10*, Bethan Psaila, MD, PhD11 and Deepti H. Radia, MRCPI, FRCPath12*

1Guy's and St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom
2University College London Hospitals NHS Foundation Trust, London, United Kingdom
3Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United Kingdom
4Royal Cornwall Hospital, Cornwall, United Kingdom
5Hull University Teaching Hospitals NHS Foundation Trust, Hull, United Kingdom
6St James University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
7Maidstone and Turnbridge Wells NHS Trust, Turnbridge Wells, United Kingdom
8Royal Derby Hospital, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom
9University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom
10Edinburgh Cancer Center, Western General Hospital, Edinburgh, United Kingdom
11MRC Weatherall Institute of Molecular Medicine, University of Oxford; Oxford University Hospitals NHS Trust, Oxford, United Kingdom
12Guy's and St. Thomas' Hospital, London, United Kingdom

Peter Loffelhardt, DO1*, Ryan Eckert, MS2*, Judit Diaz Campos1*, Ruben Mesa, MD, FACP2 and Carles Besses Raebel, MD, PhD3

1Asociación de Afectados por Neoplasias Mieloproliferativas, Barcelona, Spain
2Mays Cancer Center at UT Health San Antonio, San Antonio, TX
3Cancer Research Program-IMIM, Group of Applied Clinical Research in Hematology, Barcelona, Spain

Srdan Verstovsek, MD, PhD1, Jason Gotlib, MD, MS2, Alessandro M. Vannucchi, MD3*, Alessandro Rambaldi, MD4, Andreas Reiter, MD5, William Shomali, MD2, Tracy I. George, MD6, Jay L. Patel, MD7*, Philomena Colucci, DO, MS8*, Huiling Zhen, PhD8*, Natalia Oliveira, MBA, BS8* and Jean-Jacques Kiladjian, MD9

1University of Texas MD Anderson Cancer Center, Houston, TX
2Division of Hematology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
3University of Florence, CRIMM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
4Department of Oncology and Hematology, University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
5University Hospital Mannheim, Heidelberg University, Mannheim, Germany
6Department of Pathology, ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, UT
7ARUP Laboratories and University of Utah School of Medicine, Salt Lake City, UT
8Incyte Corporation, Wilmington, DE
9Hôpital Saint-Louis, Paris, France

Ruben Mesa, MD, FACP1, Srdan Verstovsek, MD, PhD2, Uwe Platzbecker, MD3*, Vikas Gupta, MD, FRCP, FRCPath4, David Lavie, MD5*, Pilar Giraldo, PhD6, Jean-Jacques Kiladjian, MD7, Stephen T Oh, MD, PhD8, Timothy Devos, MD, PhD9, Francesco Passamonti, MD10*, Miklos Egyed, MD, PhD11*, Alessandro Vannucchi, MD12, Andrzej Pluta, MD13*, Donal P McLornan, MD, MRCP, PhD, FRCPath14*, Jun Kawashima, MD15*, Mei Huang, MS15*, Bryan Strouse, MSc15* and Claire N. Harrison, DM16

1Mays Cancer Center at UT Health San Antonio, San Antonio, TX
2MD Anderson Cancer Center, University of Texas, Houston, TX
3Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
4Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
5Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
6Miguel Servet University Hospital and Centro de Investigacion Biomedica en Red de Enfermadades Raras (CIBERER), Zaragoza, Spain
7Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, Paris, France
8Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
9Department of Hematology and Department of Microbiology and Immunology, University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium
10University of Insubria, Varese, Italy
11Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary
12University of Florence, Azienda Ospedaliero Universitaria Careggi, CRIMM, Florence, Italy
13Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów, Poland
14Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
15Sierra Oncology Inc., San Mateo, CA
16Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom

Haris Ali, MD1, Ashwin Kishtagari, MBBS2, Keri Maher, DO3, Sanjay R Mohan, MD, MSCI4, Karen Ansaldo5*, Xulong Wang5*, Kamal Chamoun, MD5*, Josef T. Prchal, MD6 and Srinivas K. Tantravahi, MBBS7

1City of Hope Medical Center, Duarte, CA
2Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Franklin, TN
3Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ
4Vanderbilt University School of Medicine, Vanderbilt Ingram Cancer Center, Nashville, TN
5Karyopharm Therapeutics, Newton, MA
6Division of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
7Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Michal Bar-Natan, MD1, John Mascarenhas, MD2, Aaron T. Gerds, MD, MS3, Ruben Mesa, MD, FACP4, Vikas Gupta, MD, FRCP, FRCPath5, Marina Kremyanskaya, MD, PhD6, Mikaela Dougherty1*, Frank Fabris1*, Kathryn Johnson7*, Ashley Yu, MBA, BS8*, Heidi E. Kosiorek, MS9*, Carolyn Mead-Harvey, MS10*, Amylou C. Dueck, PhD9, Ronald Hoffman, MD6 and Raajit K Rampal, MD, PhD11

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
3Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Mays Cancer Center at UT Health San Antonio, San Antonio, TX
5Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
6Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
7Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
8Tisch Cancer Institute, Icahn School oh Medicine at Mount Sinai, New York, NY
9Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
10Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
11Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY

Kayleigh Rutherford, MS1*, Noushin Farnoud, PhD1*, Aishwarya Krishnan, MS2*, Raajit K Rampal, MD, PhD3, Ross L. Levine, MD1,3,4 and Nicole Kucine, MD, MS5

1Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
2Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pediatrics, Weill Cornell Medicine, New York, NY

Franco Castillo Tokumori, MD1, Joseph Scandura, MD, PhD2 and Ghaith Abu-Zeinah, MD2

1NewYork Presbyterian Hospital/ Weill Cornell, New York, NY
2Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY

Gordon Ruan, MD1, Jithma P. Abeykoon, MD1, Aldo A. Acosta Medina, MD2, Saurabh Zanwar, MBBS1*, Aishwarya Ravindran, MBBS3, Karen Rech, MD4*, Jason R. Young, MD5*, Jay Ryu, MD6*, Matthew Koster, MD7*, W. Oliver Tobin, MB BCh8*, Mithun V. Shah, MD, PhD1, N. Nora Nora Bennani, MD1, Robert Vassallo, MD6*, Baylie Brooks9*, Ginny-Tyler Meadows9*, Abby McCrory, MSN9*, Diana Morlote, MD10*, Gaurav Goyal, MD9 and Ronald Go, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Department of Radiology, Mayo Clinic, Jacksonville, FL
6Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
7Division of Rheumatology, Mayo Clinic, Rochester, MN
8Department of Neurology, Mayo Clinic, Rochester, MN
9Hematology/Oncology, University of Alabama At Birmingham, Birmingham, AL
10University of Alabama At Birmingham, Birmingham, AL

Levi-Dan Azoulay1*, Chezi Ganzel, MD2*, Marine Bravetti, MD3*, Zahir Amoura, MD, MSc4*, Jean Donadieu5, Philippe Cluzel, MD, PhD3*, Fleur Cohen-Aubart, MD, PhD1* and Julien Haroche, MD, PhD1*

1Department of Internal Medicine 2, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
2Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
3Department of Interventional and Cardiovascular Radiology, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
4Department of Internal Medicine 2, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, FRA
5Department of Pediatric Hematology-Oncology, Reference Center for Chronic Neutropenia, National Registry of Congenital Neutropenia, Hopital Trousseau, Paris, France

Reem S. Chamseddine, BSc1*, Shehroz Rana1*, Mohammed Khalid1*, Nicole Kucine, MD, MS2, Richard T. Silver, MD3, Joseph Scandura, MD, PhD3 and Ghaith Abu-Zeinah, MD3

1Weill Cornell Medicine-Qatar, Doha, Qatar
2Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY
3Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY

*signifies non-member of ASH